SCHEMBL14018297

SCHEMBL14018297

Cc1ccc(N(c2ccccc2)c2ccc(N(c3ccc(-c4ccc(N(c5ccc(N(c6ccccc6)c6ccc(C)cc6)cc5)c5cccc6ccccc56)cc4)cc3)c3cccc4ccccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 6/20 0.43
▸ NPC1 O15118 1/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ CYP2A6 P11509 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ EGFR P00533 1/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ APP P05067 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12744268 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL14018315 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL22129835 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL19763122 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL19763128 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL18569169 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL12744267 1.00 SIGMAR1 (0.43) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL17051484 0.98 SIGMAR1 (0.42) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL16386586 0.98 SIGMAR1 (0.44) SIGMAR1NPC1XBP1HTTRAB9A
SCHEMBL2607224 0.98 SIGMAR1 (0.44) SIGMAR1NPC1XBP1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080241591-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND PHENYLENEDIAMINE DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-10-02 — — US disclosed
US-20080241591-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND PHENYLENEDIAMINE DERIVATIVE IDEMITSU KOSAN CO., LTD. (JP) 2008-10-02 — — US disclosed
US-7399537-B2 Organic electroluminescence device and phenylenediamine derivative IDEMITSU KOSAN CO., LTD. (JP) 2008-07-15 — — US disclosed
US-7399537-B2 Organic electroluminescence device and phenylenediamine derivative IDEMITSU KOSAN CO., LTD. (JP) 2008-07-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080241591-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND PHENYLENEDIAMINE DERIVATIVE MAL2, L1CAM, EPCAM SIGMAR1 2487/4885NPC1 2038/4885XBP1 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback